Point-of-Care Testing (POCT) Devices

POCT Device Elastollan 1195A Standard Injection Molding with LK Forza 800T

The Engineering Challenge: Optical Purity in a Hostile Material

As a design or manufacturing engineer in the medical device space, you live and breathe precision. When your project involves Point-of-Care Testing (POCT) Devices, the stakes are amplified to an almost unforgiving level. These devices—ranging from glucose meters to complex microfluidic cartridges for infectious disease detection—rely on flawless optical pathways. The slightest imperfection, the smallest internal stress, can scatter light, distort a reading, and lead to a catastrophic misdiagnosis. This is where material selection and process control cease to be abstract concepts and become the bedrock of patient safety and device efficacy.

Enter the material specified for your next-gen diagnostic cartridge: BASF Elastollan 1195A. On paper, it's a fantastic choice. It's a medical-grade thermoplastic polyurethane (TPU) with excellent toughness, chemical resistance, and biocompatibility. But as any seasoned molding engineer knows, the datasheet is only the beginning of the story. Elastollan 1195A is notoriously difficult to process, primarily due to two intrinsic properties: high hygroscopicity and extreme shear sensitivity.

Its hygroscopic nature means it acts like a sponge for atmospheric moisture. Improper or insufficient drying—a common oversight in less disciplined shops—leads to hydrolysis during melting. This chemical breakdown of the polymer chains results in splay, silver streaking, and a catastrophic loss of mechanical properties. More insidiously for optical applications, it creates microscopic voids and inconsistencies that ruin light transmission.

The shear sensitivity is an even greater challenge. As the molten polymer is forced through the nozzle, runners, and gate into the mold cavity, it experiences immense shear forces. With a material like this TPU, excessive shear rates or inconsistent melt viscosity generate non-uniform molecular orientation. As the part cools, these orientations lock into place, creating localized areas of high internal stress. The result is stress-induced birefringence—a phenomenon where the material's refractive index becomes directional. To the naked eye, the part might look perfect. But place it between two polarizing filters, and you'll see a rainbow of stress patterns, each one a potential point of failure for your optical sensor's readout. The challenge, therefore, is not just to mold a part, but to mold a part that is, from a molecular perspective, completely relaxed and optically isotropic.

A Process Forged for Compliance: ISO 13485, FDA, and IVDR

Manufacturing for the medical field is a game of documentation, validation, and unwavering consistency. Simply producing a "good part" is insufficient. You must be able to prove, with objective data, that your process is stable, repeatable, and under control, from the first shot to the hundred-thousandth. This is where our dedicated manufacturing cell, centered around this specific material and machine combination, provides a critical advantage.

ISO 13485:2016 is the foundational standard for a medical device quality management system (QMS). It demands rigorous process validation (IQ/OQ/PQ), risk management, and traceability. Our approach directly supports these pillars. By utilizing the precision of a state-of-the-art injection molding machine, we establish a wide and stable processing window. This isn't about just finding one "golden" setting; it's about defining a robust operational range and proving that any variation within that range still yields a conforming part. The advanced monitoring capabilities of the LK Forza 800T allow us to log every critical parameter for every single cycle—injection pressure, melt temperature, cooling time, clamp tonnage. This data becomes an integral part of the Device History Record (DHR), providing an unbroken chain of evidence that each part was manufactured to spec.

FDA 21 CFR Part 820, the Quality System Regulation (QSR) in the United States, echoes and reinforces these requirements. A key focus of the QSR is on production and process controls (Subpart G). Our strategy of achieving a net-shape optical component in a single step is a massive de-risking factor from an FDA perspective. Secondary operations like stress-relieving (annealing) or polishing introduce new process variables that must be independently validated and controlled. Each additional step is another potential point of failure and another source of regulatory scrutiny. By eliminating them, we simplify the validation package, reduce risk, and shorten the time-to-market.

The European CE IVDR (In Vitro Diagnostic Regulation 2017/746) has significantly raised the bar for diagnostic devices sold in the EU, demanding more extensive clinical evidence and a life-cycle approach to safety and performance. The consistency of the components used in these devices is paramount. Our ability to counteract the inherent tendencies of Elastollan 1195A to form stress birefringence ensures that the optical performance of the disposable cartridge—a key component of the diagnostic system—is a constant, not a variable. This process stability is fundamental to demonstrating the long-term analytical performance required under IVDR.

Technical Deep Dive: Machine & Material Synergy

To overcome the challenges of Elastollan 1195A, you cannot use just any machine. You need a platform engineered for absolute stability and control. The LK Forza 800T is the core of our solution. This isn't a general-purpose press; it's a precision instrument. Here’s a breakdown of the critical parameters that make this process possible:

Deconstructing the Total Cost of Ownership (TCO)

The economic viability of a project is as critical as its technical feasibility. While the initial quote for a high-precision process might seem higher than a standard "mold-and-ship" operation, a TCO analysis reveals a different story. Our strategy is optimized for production volumes in the 5,000 to 100,000 unit range, a common requirement for clinical trials, initial product launch, and mid-life production cycles before scaling to multi-million unit automation.

The core of our economic and technical advantage lies in how we master the material's sensitivities. The high hygroscopicity and shear sensitivity of this TPU are the primary drivers of yield loss in typical molding operations. The formation of stress birefringence is a silent yield killer, often only discovered during functional QC testing of the final assembled device, leading to costly scrap of not just the molded part, but the entire assembly.

Our solution attacks this problem at its root. The LK Forza 800T's two-platen clamping mechanism is the first line of defense. Unlike toggle-clamp machines which can exhibit "platen breathing" under pressure, the direct-locking hydraulic system of a two-platen press offers exceptional rigidity. This rigidity ensures that the mold halves remain perfectly parallel and sealed, even under the immense pressures required to inject a viscous material like Elastollan 1195A. This guarantees that cavity pressure is distributed uniformly across every millimeter of the part surface. This uniformity is what directly counteracts the formation of differential shrinkage, sink marks, and locked-in stress.

The second critical element is the precision servo-hydraulic system. For a shear-sensitive polymer, the injection profile is everything. We don't just "fill the part." We meticulously control the velocity profile across multiple stages to manage the shear rate as the melt front progresses through the cavity. The switchover from the velocity-controlled injection phase to the pressure-controlled holding phase is executed with sub-millisecond precision. This prevents over-packing at the gate while ensuring sufficient pressure is maintained to compensate for volumetric shrinkage as the part cools. This meticulous control over the injection and holding phases is what allows us to manage the material's sensitive melt viscosity and achieve a stress-free state.

By combining these machine capabilities with rigorous material handling (e.g., using desiccant dryers with dew point monitoring), we achieve what every medical device engineer desires: a net-shape, FDA and ISO 13485 compliant optical window in a single, repeatable process. The economic impact is profound. We eliminate the significant risk, cost, and process validation burden associated with secondary stress-relieving or polishing operations. Your TCO is dramatically reduced because the cost per good, usable, compliant part is lower. You avoid the hidden factory of rework, the scrap costs of failed QC, and the schedule delays that plague less-controlled processes.

Conclusion: From Engineering Challenge to Manufacturing Certainty

Molding optically pure components from Elastollan 1195A is a significant engineering hurdle. It demands more than just a molding machine; it requires a holistic system of material science, process engineering, and metrology. At MechanoFab, we have engineered that exact system. We have transformed a high-risk manufacturing problem into a predictable, validated, and cost-effective solution, enabling you to bring your next-generation POCT devices to market faster and with greater confidence.